Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.
about
Effects of hydrogen peroxide on wound healing in mice in relation to oxidative damagePharmacotherapy of systemic sclerosisModulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy.Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesRecent developments in myofibroblast biology: paradigms for connective tissue remodelingIntrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic SclerosisProteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis.Alteration of fibroblast phenotype by asbestos-induced autoantibodiesFibroblast heterogeneity in physiological conditions and fibrotic disease.Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis.Emerging targets for the treatment of scleroderma.Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblastsThe mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contracturesTargeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.Pathogenesis of Systemic Sclerosis.Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblastsThe mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Lentivirus-mediated ERK2 siRNA reduces joint capsule fibrosis in a rat model of post-traumatic joint contracture.B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosisAnti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.Matrix remodeling in systemic sclerosis.Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosisThe significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseasesEndothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k).Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice.Human Fibrotic Diseases: Current Challenges in Fibrosis Research.Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine modelThe inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis
P2860
Q21133900-22FEA5D2-6640-44AE-850E-0D1017F5F1FDQ24629481-6613B989-71F3-45C9-A46C-2CE13CF89A88Q24802425-29089F38-0501-43EB-AEAA-DF274C3EF7D1Q26748338-A5BAE88A-0521-48D2-B8BE-6F445F201F09Q26863751-7927D78A-75C2-4AA6-A91E-4799D7B235AEQ28551230-2C528B4A-C346-448F-AE5B-C7CF9CF9FE3AQ33665990-4E32AF19-5CA2-47FE-8E51-1E506E29B5BEQ33708683-9568732D-AE7C-4B9D-A569-8FD29419816EQ33808382-30821F41-AAFE-4A02-9921-4C26C12E0E78Q33860249-8CCCB550-9FC8-4734-9C60-98EF3ABDAC6FQ34005595-C3FCE2BF-9384-4B5D-94F1-E6E550C73B24Q34005608-959759DD-BE44-4B83-BC6A-60D1D11192FBQ34270856-43F7C3E2-1333-4ADD-A8CD-84F0DFCD6077Q34310766-FCFE5772-940A-4489-944E-E878E5108266Q34550614-E7767B78-A636-40BD-8088-2CF743D91C61Q35102837-27017AC0-419B-4C0E-B80C-AD680B6E114BQ35550841-EA8FFFF1-CA6D-44F6-981F-60CBD2B24CDFQ35693212-F37CFEFE-A769-4A8B-BF70-5FBA0C0F1E79Q36023711-CDF39C4D-2BED-4550-AFE9-CB51A731112FQ37008430-F1EF0332-06BB-4BA0-B0AD-69F45D9B752CQ37224668-8D67B54C-52DA-4868-AD2D-0FCB1B4E23BDQ37291369-DA9C8A38-578D-416F-8E4B-82520058E8A0Q37690672-5B0B86E3-7DDB-4D65-A9B7-E6EEB32A190AQ37854935-EEA08176-3378-46A7-BB69-2B130EC7AE14Q38542590-AB7EDAF6-F13B-400D-83CE-390BED7F6B2CQ38710580-C908F879-83C9-4ED0-A59A-78CABC394B4FQ38843287-0610611E-9F42-4D4C-AFA7-7685D68A9252Q39211384-5377078C-1FFF-4701-847F-A5701E5683BAQ40902696-837B27B6-E294-42AB-AF19-BC2235C3FEFDQ42474271-80F30890-76F0-4605-9610-F26EB8E2D460Q42494727-53E0AAA8-1092-4858-A443-EF1677AD1C00Q45874899-03339C9E-ADCD-4BF8-ADF2-B600FB438815Q52536468-561508DE-05B4-4718-A512-FCFC7A611786Q58003958-5AA556F5-831E-40EB-B030-E55BE1AA9CD7Q58479877-E1528D9D-D62E-4739-97E3-44FA0D96CEB6
P2860
Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Myofibroblasts from scleroderm ...... P-1) with two forms of TIMP-1.
@en
type
label
Myofibroblasts from scleroderm ...... P-1) with two forms of TIMP-1.
@en
prefLabel
Myofibroblasts from scleroderm ...... P-1) with two forms of TIMP-1.
@en
P2093
P2860
P356
P1476
Myofibroblasts from scleroderm ...... P-1) with two forms of TIMP-1.
@en
P2093
P2860
P304
P356
10.1074/JBC.270.7.3423
P407
P577
1995-02-01T00:00:00Z